We performed IF and WB assays on key proteins of the PI3K/AKT/STAT6 pathways to elucidate the molecular mechanism by which QRHXF promotes metastasis in tumor cells and augments checkpoint immunotherapy. The gene discussed is AKT1; the disease is neoplasm.